Euphrasia eye drops in preterm neonates with ocular discharge: a randomized double-blind placebo-controlled trial

Meier-Girard, D., Gerstenberg, G., Stoffel, L., Kohler, T., Klein, S.D., Eschenmoser, M., Mitter, V.R., Nelle, M. and Wolf, U. · Frontiers in Pediatrics · 2020

Randomized trial

View original source →

Abstract

In a randomized double-blind placebo-controlled trial, Euphrasia eye drops were evaluated for ocular discharge in preterm neonates, supporting the anti-inflammatory ophthalmic use of eyebright.

Referenced for these plants

How to cite

Meier-Girard, D., Gerstenberg, G., Stoffel, L., Kohler, T., Klein, S.D., Eschenmoser, M., Mitter, V.R., Nelle, M. and Wolf, U (2020) 'Euphrasia eye drops in preterm neonates with ocular discharge: a randomized double-blind placebo-controlled trial', Frontiers in Pediatrics, 8, pp. 449. doi:10.3389/fped.2020.00449

This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.